Jackson Square Capital, LLC Catalent, Inc. Transaction History

Jackson Square Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	SELL	$94.19 - $124.49 $186,119 - $245,992	-1,976 Closed	0 $0
Q4 2021 Jan 19, 2022	SELL	$119.57 - $139.07 $232,444 - $270,352	-1,944 Reduced 49.59%	1,976 $253,000
Q3 2021 Oct 21, 2021	SELL	$109.17 - $142.35 $6,550 - $8,541	-60 Reduced 1.51%	3,920 $522,000
Q1 2021 May 18, 2021	SELL	$101.51 - $125.27 $21,824 - $26,933	-215 Reduced 5.13%	3,980 $419,000
Q4 2020 Mar 05, 2021	BUY	$85.88 - $105.36 $360,266 - $441,985	4,195 New	4,195 $437,000
Q1 2020 May 15, 2020	SELL	$36.95 - $62.95 $3,325 - $5,665	-90 Closed	0 $0
Q4 2019 May 15, 2020	BUY	$47.06 - $56.64 $4,235 - $5,097	90 New	90 $5,000

490

165M

364K

837K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Jackson Square Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Square Capital, LLC with notifications on news.